Trials / Completed

CompletedNCT00108290

Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer

Chemohormone Therapy Prior to Prostatectomy in High Risk Prostate Cancer

Status: Completed
Phase: Phase 2
Study type: Interventional
Enrollment: —

Sponsor: US Department of Veterans Affairs · Federal
Sex: Male
Age: 18 Years – 80 Years
Healthy volunteers: Not accepted

Summary

In men with prostate cancer who do not have evidence of spread to bone or other sites on computed axial tomography (CAT) scan/bone scan but are still at significant risk of failing treatment with surgery or radiation alone, a combination of chemotherapy and hormone therapy is being given for 6 months followed by surgery to remove the prostate.

Conditions

Prostate Cancer

Interventions

Type	Name	Description
DRUG	Chemotherapy

Timeline

Start date: 2004-04-01
Completion: 2007-03-01
First posted: 2005-04-15
Last updated: 2008-04-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00108290. Inclusion in this directory is not an endorsement.